-
Section BC CDA Allergies and Intolerances Section (entries optional) (V3) (2.16.840.1.113883.3.51.60.3.8)
-
Entry BC CDA Allergy Concern Act (V3) (2.16.840.1.113883.3.51.60.3.7)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry BC CDA Allergy - Intolerance Observation (V2) (2.16.840.1.113883.3.51.60.3.6)
-
Entry BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
-
BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
-
BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
-
Entry BC CDA Reaction Observation (V2) (2.16.840.1.113883.3.51.60.3.3)
-
Entry BC CDA Procedure Activity Procedure (V2) (2.16.840.1.113883.3.51.60.3.4)
-
Entry Product Instance (2.16.840.1.113883.10.20.22.2.86)
-
Entry Prognosis Observation (2.16.840.1.113883.10.20.22.2.75)
-
Entry Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
-
Entry Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
-
Entry Reaction Observation (V2) (2.16.840.1.113883.10.20.22.2.58)
-
Entry Severity Observation (V2) (2.16.840.1.113883.10.20.22.2.59)
-
Entry Severity Observation (V2) (2.16.840.1.113883.10.20.22.2.59)
-
Entry Severity Observation (V2) (2.16.840.1.113883.10.20.22.2.59)
-
Entry Criticality Observation (2.16.840.1.113883.10.20.22.2.84)
|